Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement.
Resource Type
Academic Journal
Authors
Hiemcke-Jiwa LS; a Department of Pathology , University Medical Center Utrecht , Utrecht , The Netherlands.; Leguit RJ; a Department of Pathology , University Medical Center Utrecht , Utrecht , The Netherlands.; Radersma-van Loon JH; a Department of Pathology , University Medical Center Utrecht , Utrecht , The Netherlands.; Westerweel PE; b Department of Internal Medicine , Albert Schweitzer hospital Dordrecht , Dordrecht , The Netherlands.; Rood JJM; c Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology , Utrecht University, Faculty of Science , Utrecht , The Netherlands.; Doorduijn JK; d Department of Hematology , Erasmus Cancer Institute Rotterdam , Rotterdam , The Netherlands.; Huibers MMH; a Department of Pathology , University Medical Center Utrecht , Utrecht , The Netherlands.; Minnema MC; e Department of Hematology , University Medical Center Utrecht Cancer Center , Utrecht , The Netherlands.
Source
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE